SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-016897
Filing Date
2022-08-11
Accepted
2022-08-11 16:22:45
Documents
71
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q kzr-20220630.htm   iXBRL 10-Q 2743892
2 EX-10.1 kzr-ex10_1.htm EX-10.1 272855
3 EX-10.2 kzr-ex10_2.htm EX-10.2 120571
4 EX-31.1 kzr-ex31_1.htm EX-31.1 21326
5 EX-31.2 kzr-ex31_2.htm EX-31.2 21327
6 EX-32.1 kzr-ex32_1.htm EX-32.1 12853
7 GRAPHIC img38312587_0.jpg GRAPHIC 71685
  Complete submission text file 0000950170-22-016897.txt   9874086

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kzr-20220630_lab.xml EX-101.LAB 420854
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kzr-20220630_pre.xml EX-101.PRE 306421
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kzr-20220630.xsd EX-101.SCH 52240
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kzr-20220630_cal.xml EX-101.CAL 44771
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kzr-20220630_def.xml EX-101.DEF 160545
65 EXTRACTED XBRL INSTANCE DOCUMENT kzr-20220630_htm.xml XML 1832779
Mailing Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-822-5600
Kezar Life Sciences, Inc. (Filer) CIK: 0001645666 (see all company filings)

IRS No.: 473366145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38542 | Film No.: 221156211
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences